Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Extended-release oxycodone
(Synonym: D05462)		[1] Oxycodone[3] D03783 ,
D05312 ,
D05462 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
2Oxycodone
(Synonym: D05462)		[1] Oxycodone[3] D03783 ,
D05312 ,
D05462 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[7] 6, 13, 46, 70, 226, 231, 298
3Oxycodone by patient-controlled analgesia (PCA)
(Synonym: D05462)		[1] Oxycodone[3] D03783 ,
D05312 ,
D05462 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 46
4Oxycodone Depot ”Sandoz”, depot tablets
(Synonym: D05462)		[1] Oxycodone[3] D03783 ,
D05312 ,
D05462 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 298
5OXYCODONE HYDROCHLORIDE
(Synonym: D05462)		[1] Oxycodone[3] D03783 ,
D05312 ,
D05462 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[4] 6, 70, 226, 298
6Oxycodone naloxone prolonged release tablets
(Synonym: D05462)		[2] Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
7Oxycodone Orion
(Synonym: D05462)		[1] Oxycodone[3] D03783 ,
D05312 ,
D05462 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 70
8Oxycodone/Acetaminophen
(Synonym: D05462)		[2] Acetaminophen,
Oxycodone		[4] D00217 ,
D03783 ,
D05312 ,
D05462 		[5] OPRD1,
OPRK1,
OPRM1,
PTGS1,
PTGS2 💬		[28] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Sphingolipid signaling pathway, TNF signaling pathway, VEGF signaling pathway, cGMP-PKG signaling pathway 💬[1] 231
9Oxycodone/naloxone prolonged release t
(Synonym: D05462)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
10Oxycodone/Naloxone Prolonged Release tablets
(Synonym: D05462)		[2] Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
11Oxycodone/naloxone prolonged release tablets 10 mg /5 mg
(Synonym: D05462)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
12Oxycodone/naloxone prolonged release tablets 10/5 mg
(Synonym: D05462)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
13Oxycodone/naloxone prolonged release tablets 20 mg /10 mg
(Synonym: D05462)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
14Oxycodone/naloxone prolonged release tablets 20/10 mg
(Synonym: D05462)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
15Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg
(Synonym: D05462)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
16Oxycodone/naloxone prolonged release tablets 5/2.5 mg
(Synonym: D05462)		[3] Manganese citrate,
Naloxone,
Oxycodone		[5] D01340 ,
D03783 ,
D05312 ,
D05462 ,
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
17PR Oxycodone
(Synonym: D05462)		[1] Oxycodone[3] D03783 ,
D05312 ,
D05462 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6